Stimulatory effect of insulin on theca-interstitial cell proliferation and cell cycle regulatory proteins through MTORC1 dependent pathway

Molecular and Cellular Endocrinology

Volumn 366, Issue 1, 2013, Pages 81-89

  Palaniappan, Murugesan ^a,b   Menon, Bindu ^a   Menon, K M J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle regulatory proteins; Insulin; MTORC1; RPS6KB1; Theca interstitial cells

Indexed keywords

CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE NUCLEIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; THECA INTERSTITIAL CELL;

ANIMALS; CARRIER PROTEINS; CATTLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; FEMALE; GENE SILENCING; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MULTIPROTEIN COMPLEXES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIROLIMUS; THECA CELLS; TIME FACTORS; TOR SERINE-THREONINE KINASES;

EID: 84872498011     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.12.004     Document Type: Article

References (49)

1. Alam H., Maizels E.T., Park Y., Ghaey S., Feiger Z.J., Chandel N.S., Hunzicker-Dunn M. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J. Biol. Chem. 2004, 279:19431-19440.
2. Arvisais E., Hou X., Wyatt T.A., Shirasuna K., Bollwein H., Miyamoto A., Hansen T.R., Rueda B.R., Davis J.S. Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase. Mol Endocrinol. 2010, 24:632-643.
3. Bandi H.R., Ferrari S., Krieg J., Meyer H.E., Thomas G. Identification of 40 S ribosomal protein S6 phosphorylation sites in Swiss mouse 3T3 fibroblasts stimulated with serum. J. Biol. Chem. 1993, 268:4530-4533.
4. Carriere A., Romeo Y., Acosta-Jaquez H.A., Moreau J., Bonneil E., Thibault P., Fingar D.C., Roux P.P. ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J. Biol. Chem. 2011, 286:567-577.
5. Chou M.M., Blenis J. The 70kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr Opin Cell Biol. 1995, 7:806-814.
6. Diamanti-Kandarakis E., Papavassiliou A.G. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006, 12:324-332.
7. Dowling R.J., Topisirovic I., Alain T., Bidinosti M., Fonseca B.D., Petroulakis E., Wang X., Larsson O., Selvaraj A., Liu Y., et al. MTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010, 328:1172-1176.
8. Duleba A.J., Spaczynski R.Z., Arici A., Carbone R., Behrman H.R. Proliferation and differentiation of rat theca-interstitial cells: comparison of effects induced by platelet-derived growth factor and insulin-like growth factor-I. Biol. Reprod. 1999, 60:546-550.
9. Duleba A.J., Spaczynski R.Z., Olive D.L., Behrman H.R. Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol. Reprod. 1997, 56:891-897.
10. Duleba A.J., Spaczynski R.Z., Olive D.L., Behrman H.R. Divergent mechanisms regulate proliferation/survival and steroidogenesis of theca-interstitial cells. Mol. Hum. Reprod. 1999, 5:193-198.
11. Ekim B., Magnuson B., Acosta-Jaquez H.A., Keller J.A., Feener E.P., Fingar D.C. MTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression. Mol. Cell Biol. 2011, 31:2787-2801.
12. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
13. Fingar D.C., Richardson C.J., Tee A.R., Cheatham L., Tsou C., Blenis J. MTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell Biol. 2004, 24:200-216.
14. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 2002, 16:1472-1487.
15. Gallagher E.J., LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol. Metab. 2010, 21:610-618.
16. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12:9-22.
17. Hou X., Arvisais E.W., Davis J.S. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase. Endocrinology 2010, 151:2846-2857.
18. Inoki K., Corradetti M.N., Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 2005, 37:19-24.
19. Kayampilly P.P., Menon K.M.J. Follicle-stimulating hormone increases tuberin phosphorylation and mammalian target of rapamycin signaling through an extracellular signal-regulated kinase-dependent pathway in rat granulosa cells. Endocrinology 2007, 148:3950-3957.
20. Kwintkiewicz J., Giudice L.C. The interplay of insulin-like growth factors, gonadotropins, and endocrine disruptors in ovarian follicular development and function. Semin. Reprod. Med. 2009, 27:43-51.
21. Kwintkiewicz J., Spaczynski R.Z., Foyouzi N., Pehlivan T., Duleba A.J. Insulin and oxidative stress modulate proliferation of rat ovarian theca-interstitial cells through diverse signal transduction pathways. Biol. Reprod. 2006, 74:1034-1040.
22. Lane H.A., Fernandez A., Lamb N.J., Thomas G. P70s6k function is essential for G1 progression. Nature 1993, 363:170-172.
23. Li S., Brown M.S., Goldstein J.L. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:3441-3446.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
25. Ma X.M., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Natl. Rev. Mol. Cell Biol. 2009, 10:307-318.
26. Magoffin D.A. The ovarian androgen-producing cells: a 2001 perspective. Rev. Endocr. Metab. Disord. 2002, 3:47-53.
27. Magoffin D.A. Ovarian theca cell. Int. J. Biochem. Cell Biol. 2005, 37:1344-1349.
28. Manning B.D., Cantley L.C. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem. Soc. Trans. 2003, 31:573-578.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
30. Myers M.G., White M.F. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 1993, 42:643-650.
31. Ning J., Clemmons D.R. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Mol. Endocrinol. 2010, 24:1218-1229.
32. Ortega H.H., Rey F., Velazquez M.M., Padmanabhan V. Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol. Reprod. 2010, 82:1065-1075.
33. Palaniappan M., Menon K.M.J. Regulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells. Biol. Reprod. 2009, 81:284-292.
34. Palaniappan M., Menon K.M.J. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway. Mol. Endocrinol. 2010, 24:1782-1793.
35. Palaniappan M., Menon K.M.J. Luteinizing hormone/human chorionic gonadotropin-mediated activation of mtorc1 signaling is required for androgen synthesis by theca-interstitial cells. Mol. Endocrinol. 2012, 26:1732-1742.
36. Price D.J., Grove J.R., Calvo V., Avruch J., Bierer B.E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 1992, 257:973-977.
37. Rapley J., Oshiro N., Ortiz-Vega S., Avruch J. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. J. Biol. Chem. 2011, 286:38043-38053.
38. Reinhard C., Fernandez A., Lamb N.J., Thomas G. Nuclear localization of p85s6k: functional requirement for entry into S phase. EMBO J. 1994, 13:1557-1565.
39. Rice S., Christoforidis N., Gadd C., Nikolaou D., Seyani L., Donaldson A., Margara R., Hardy K., Franks S. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum. Reprod. 2005, 20:373-381.
40. Ruvinsky I., Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 2006, 31:342-348.
41. Shima H., Pende M., Chen Y., Fumagalli S., Thomas G., Kozma S.C. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 1998, 17:6649-6659.
42. Spicer L.J., Aad P.Y., Allen D.T., Mazerbourg S., Payne A.H., Hsueh A.J. Growth differentiation factor 9 (GDF9) stimulates proliferation and inhibits steroidogenesis by bovine theca cells: influence of follicle size on responses to GDF9. Biol. Reprod. 2008, 78:243-253.
43. Tee A.R., Blenis J., Proud C.G. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett. 2005, 579:4763-4768.
44. Wahdan-Alaswad R.S., Song K., Krebs T.L., Shola D.T., Gomez J.A., Matsuyama S., Danielpour D. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res. 2010, 70:9106-9117.
45. Will M.A., Palaniappan M., Peegel H., Kayampilly P., Menon K.M.J. Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation. Fertil. Steril. 2012, 98:207-214.
46. Wood J.R., Strauss J.F. Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev. Endocr. Metab. Disord. 2002, 3:33-46.
47. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
48. Young J.M., McNeilly A.S. Theca: the forgotten cell of the ovarian follicle. Reproduction 2010, 140:489-504.
49. Zheng W., Nagaraju G., Liu Z., Liu K. Functional roles of the phosphatidylinositol 3-kinases (PI3Ks) signaling in the mammalian ovary. Mol. Cell Endocrinol. 2012, 356:24-30.